HSF1 and Other metabolic disease: Treating mice with HN-001 efficiently attenuated obesity by inducing a thermogenic program alongside HSF1/PGC-1α axis activation in adipose tissue (Figure 8/Graphic abstract), indicating that HN-001 is an interesting candidate for the treatment of metabolic disorders.